Composition
- Active ingredients
- GOLIMUMAB-SLDI 100MG/1ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- GOLIMUMAB-SLDI 100MG/1ML · InjectionThis page
- GOLIMUMAB-SLDI 50MG/0.5ML · InjectionBLA761452-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761452.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Immgolis
- Active substance
- golimumab-sldi
- Route
- Solution
- Dosage form
- Injection
- Applicant
- Accord Biopharma Inc.
- Status
- Prescription
- FDA approval
- 15 May 2026
- Application
- BLA761452-002